Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer

Katherine O’Connor, Deniz Erkok, Josephine A. Wright, Paige Steppe, Kate R. Barratt, Laura Vrbanac, Dan L. Worthley, Susan L. Woods, Jeff Hasty
Communications Medicine · Springer Nature · 2026-11-18 · DOI: 10.1038/s43856-026-01992-x

Abstract

Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer and capture strain- and patient-specific responses. Both bacteria preferentially colonise tumours, but attenuated Salmonella shows stronger colonisation and biological effects than E. coli Nissle.

Read at publisher →

Similar articles